The MyoMobile study will explore the UMANA T1 Heart Monitor, a novel real-time remote cardiac monitoring device. MyoMobile is a prospective, randomized study investigating the effect of a personalized mobile health intervention on the physical activity levels in patients with heart failure
Latest news
Investor
04.06.2026
Gpi to Meet Investors
European Midcap Event (9 June), Italian Day in Vienna (11 June), Mid & Small Virtual (30 June - 2 July)
Investor
18.05.2026
Gpi to Meet Investors, 19 May 2026
Northern MidCap Event, 19 May 2026 (online)
Investor
13.05.2026
Q1 2026, Gpi Expands Internationally
New contracts worth over €9 million across four continents
